CoChat

Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?

El-Mallakh, Rif S., Briscoe, Brian · 2012 · CNS Drugs

The DOI matches its Crossref record, with a small difference in title or year; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Depression is a recurrent illness in which afflicted individuals have an increased risk for recurrence as a function of a greater number of previous episodes. Consequently, prevention of future episodes is central to improving the prognosis. The current recommendation is to use antidepressants over prolonged periods of time to prevent further episodes of depression. However, the database for this practice is limited and can be interpreted in multiple ways. Review of the relevant literature was performed. MEDLINE and PubMed databases were searched from inception to 5 September 2011 for randomized, placebo-controlled trials of at least 18 months duration. After treatment of an acute depressive episode, antidepressants clearly prevent relapse back into the same depressive episode. This is demonstrated by an adequate number of randomized, blinded, placebo-controlled, 1-year continuation trials. The ability of antidepressants to prevent recurrence of future episodes is less clear. Randomized, blinded, placebo-controlled trials of 18 months or longer are infrequent - 18 studies were identified. While nearly all show that antidepressant continuation is superior to placebo in preventing resurgence of depressive symptoms, nearly all of the difference occurs in the first 6 months after randomization. This pattern strongly suggests that the apparent superiority of antidepressants may be due to (i) their ability to prevent recurrence, (ii) antidepressant withdrawal (characterized by depr…

Overview

Integrity signals

Registry

Crossref · 10.2165/11599450-000000000-00000

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 67 references

Research works printed but not linked: 6

  1. 2000, Am J Psychiatry, 157, 1
  2. Brunoni, 2009, Ther Clin Risk Manag, 5, 897
  3. Robinson, 1991, Psychopharmacol Bull, 27, 31
  4. Gilaberte, 2001, J Clin Psychopharmacol, 21, 417, 10.1097/00004714-200108000-00009 · DOI · Paper page
  5. Schatzberg, 2006, J Clin Psychiatry, 67, 27
  6. Delgado, 2006, J Clin Psychiatry, 67, 22

Cited by

See all 38

Metadata

Authors
El-Mallakh, R. S., & Briscoe, B.
Affiliations
University of Louisville (US)
Venue
CNS Drugs
Published
2012-02
Volume
26
Issue
2
Pages
97-109
ISSN
1172-7047 (ISSN-L)
OpenAlex
W88939737
Cited by
36
References
67
Citations by year
2025: 1 · 2024: 5 · 2021: 4 · 2020: 3 · 2019: 4 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 2
FWCI
0.56
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Bristol-Myers Squibb
  • Pfizer
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
antidepressants, long-term antidepressant use, depression, relapse prevention, recurrence prevention, antidepressant discontinuation, depressive symptoms
MeSH terms
Antidepressive Agents, Depressive Disorder, Humans, Statistics as Topic, Time Factors, Randomized Controlled Trials as Topic, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted? https://app.cochat.ai/papers/10.2165/11599450-000000000-00000
The paper
El-Mallakh, R. S., & Briscoe, B. (2012). Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted? CNS Drugs. https://doi.org/10.2165/11599450-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.